Shmuel Shany
Co-Founder, President & CEO
Claimed by owner Neurolief
Former names:
Brain Neuromodulation Technology
Neurolief
www.einpresswire.com
•
Jun 29, 2022
Neurolief Announces Publication of the RIME Pivotal Study for Relivion MG - a Digital Therapeutics Platform for Migraine
www.einpresswire.com
•
Jun 9, 2022
Neurolief's Digital Therapeutics Neuromodulation System May Challenge Medication Therapies for the Treatment of Migraine
www.businesswire.com
•
Jul 7, 2021
Neurolief Announces Exclusive Licensing Agreement with NeuroFront for Development and Commercialization of Relivion® in Greater China and South Korea
www.businesswire.com
•
Mar 2, 2021
Relivion® Wearable Brain Neuromodulation Technology Cleared by FDA for the Treatment of Migraine
business.theeveningleader.com
•
Jan 28, 2021
Neurolief and Sawai Enter into Exclusive Development and Marketing Agreement for Relivion®
www.businesswire.com
•
Jan 6, 2021
Neurolief Announces Positive Results From RIME Clinical Study of Its Brain Neuromodulation System for Treating Acute Migraine
www.businesswire.com
•
Aug 10, 2020
Neurolief Awarded Breakthrough Device Designation from FDA for Wearable Technology to Address Major Depression
www.calcalistech.com
•
Jul 14, 2019
This Headset Could Treat Migraines
neuronewsinternational.com
•
Jul 10, 2019
Neurolief's neuromodulation digital treatment for migraine gets CE mark
www.businesswire.com
•
Jul 9, 2019
Neurolief Receives CE Mark for Relivion™ - First Non-Invasive, Adaptive Neuromodulation Digital Treatment for Migraine
www.businesswire.com
•
Jan 9, 2019
Neurolief's Relivion™ Digital Therapeutics Brain Neuromodulation Technology Highlighted at 4th Annual International Headache Symposium in Israel
www.israel21c.org
•
Dec 5, 2018
Migraine relief from an Israeli neuro-modulation device
www.globes.co.il
•
May 9, 2018
Neurolief develops non-invasive migraine treatment
About
Neurolief develops treatments for patients with chronic neurological and neuropsychiatric disorders. The company has created a digital therapeutics platform of clinically proven neuromodulation-based solutions that can be delivered to patients at home or in the community.
Neuroliefs Relivion is a noninvasive multichannel brain neuromodulation system for treating neurological and neuropsychiatric disorders. It offers precise, personalized care by delivering stimulation to six branches of the occipital and trigeminal nerves via three adaptive output channels. This creates a cumulative effect by releasing neurotransmitters in the brainstem to modulate the brain networks associated with pain and mood control.
The Relivion device is placed comfortably on the patients head, where it stimulates the nerves. The connected e-Relief mobile app displays the treatment status and transmits information between the patient and the cloud.
The Relivion system is FDA approved and CE marked and has been granted breakthrough device designation by the FDA.
Neuroliefs Relivion is a noninvasive multichannel brain neuromodulation system for treating neurological and neuropsychiatric disorders. It offers precise, personalized care by delivering stimulation to six branches of the occipital and trigeminal nerves via three adaptive output channels. This creates a cumulative effect by releasing neurotransmitters in the brainstem to modulate the brain networks associated with pain and mood control.
The Relivion device is placed comfortably on the patients head, where it stimulates the nerves. The connected e-Relief mobile app displays the treatment status and transmits information between the patient and the cloud.
The Relivion system is FDA approved and CE marked and has been granted breakthrough device designation by the FDA.
Primary Sector
Life Sciences & HealthTech
Products
Relivion
Geographic markets
United States, China, Japan, South Korea, Europe
News
(13)
www.einpresswire.com
•
Jun 29, 2022
Neurolief Announces Publication of the RIME Pivotal Study for Relivion MG - a Digital Therapeutics Platform for Migraine
www.einpresswire.com
•
Jun 9, 2022
Neurolief's Digital Therapeutics Neuromodulation System May Challenge Medication Therapies for the Treatment of Migraine
www.businesswire.com
•
Jul 7, 2021
Neurolief Announces Exclusive Licensing Agreement with NeuroFront for Development and Commercialization of Relivion® in Greater China and South Korea
www.businesswire.com
•
Mar 2, 2021
Relivion® Wearable Brain Neuromodulation Technology Cleared by FDA for the Treatment of Migraine
business.theeveningleader.com
•
Jan 28, 2021
Neurolief and Sawai Enter into Exclusive Development and Marketing Agreement for Relivion®
www.businesswire.com
•
Jan 6, 2021
Neurolief Announces Positive Results From RIME Clinical Study of Its Brain Neuromodulation System for Treating Acute Migraine
www.businesswire.com
•
Aug 10, 2020
Neurolief Awarded Breakthrough Device Designation from FDA for Wearable Technology to Address Major Depression
www.calcalistech.com
•
Jul 14, 2019
This Headset Could Treat Migraines
neuronewsinternational.com
•
Jul 10, 2019
Neurolief's neuromodulation digital treatment for migraine gets CE mark
www.businesswire.com
•
Jul 9, 2019
Neurolief Receives CE Mark for Relivion™ - First Non-Invasive, Adaptive Neuromodulation Digital Treatment for Migraine
www.businesswire.com
•
Jan 9, 2019
Neurolief's Relivion™ Digital Therapeutics Brain Neuromodulation Technology Highlighted at 4th Annual International Headache Symposium in Israel
www.israel21c.org
•
Dec 5, 2018
Migraine relief from an Israeli neuro-modulation device
www.globes.co.il
•
May 9, 2018
Neurolief develops non-invasive migraine treatment
The Team
(3)
SS
Amit Dar
Co-founder & CTO
Ron Belson
VP R&D
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Seed
$1.3M
Jan 2015
2 Investors
$1.3M
A Round
$4M
Jun 2017
2 Investors
$4M
Use Cases (1)
Media gallery
(1)
Relivion Brain Neuromodulation - How it works
Locations
Israel
Sderot Giborei Israel 12, Netanya, Israel
Offices Abroad
Tampa, FL, USA
Locations
Israel
Sderot Giborei Israel 12, Netanya, Israel
Offices Abroad
Tampa, FL, USA
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,